Target Name: C5orf67
NCBI ID: G101928448
Review Report on C5orf67 Target / Biomarker Content of Review Report on C5orf67 Target / Biomarker
C5orf67
Other Name(s): uncharacterized LOC101928448 | Protein LOC101928448 | chromosome 5 putative open reading frame 67 | CE067_HUMAN | Uncharacterized protein LOC101928448 | uncharacterized protein LOC101928448 | Uncharacterized protein C5orf67 | Chromosome 5 open reading frame 67

LOC101928448: A Potential Drug Target or Biomarker

LOC101928448 is a gene located at position 6,856,670 on chromosome 17. It is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. This molecule is of interest due to its unique structure, its expression patterns in various tissues, and its potential involvement in various biological processes.

Structure and Expression

LOC101928448 is a long non-coding RNA molecule that has a length of approximately 29 kilobases (kb). It is expressed in various tissues, including brain, heart, and liver. It is predominantly expressed in the brain, where it is found at relatively high levels. The expression pattern of LOC101928448 is highly tissue-specific, which suggests that it may play a specific role in different brain regions.

Function

The function of LOC101928448 is not yet fully understood. However, several studies have suggested that it may be involved in various biological processes, including cell signaling, metabolism, and stress response.

One potential function of LOC101928448 is as a drug target. The unique structure of this molecule, as well as its expression patterns in various tissues, make it an attractive target for drug development. Additionally, the fact that LOC101928448 is expressed in the brain, which is a known hub for drug resistance, suggests that it may be particularly vulnerable to drug intervention.

Another potential function of LOC101928448 is as a biomarker. The expression patterns of this molecule have been observed in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Additionally, the fact that LOC101928448 is expressed in most tissues of the body suggests that it may be a useful biomarker for diagnostic purposes.

Sequence Analysis

To better understand the function of LOC101928448, its sequence has been analyzed using various techniques, including RNA sequencing (RNA-seq), microarray analysis, and bioinformatics analysis. The results of these studies have provided valuable insights into the molecular structure and function of this molecule.

One of the most significant findings of the sequence analysis is the presence of a unique stem-loop region in the LOC101928448 molecule. This region has been shown to be involved in the formation of stem-loop structures, which are commonly found in non-coding RNAs. The stem-loop region is also known as a potential binding site, which suggests that it may play a role in the interaction with other molecules.

Additionally, the sequence analysis has revealed the presence of a highly conserved region in the LOC101928448 molecule. This region is known as the T-loop and is commonly found in non-coding RNAs. The T-loop is involved in the formation of stem-loop structures and has been shown to be involved in various cellular processes.

Conclusion

LOC101928448 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure, expression patterns in various tissues, and potential involvement in various biological processes make it an attractive target for further study. The results of sequence analysis have provided valuable insights into the molecular structure and function of this molecule, which may have implications for future drug development and diagnostic applications.

Protein Name: Chromosome 5 Putative Open Reading Frame 67

The "C5orf67 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C5orf67 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C6 | C6orf118 | C6orf120 | C6orf132 | C6orf136 | C6orf141 | C6orf15 | C6orf163 | C6orf226 | C6orf47 | C6orf52 | C6orf58 | C6orf62 | C6orf89 | C7 | C7orf13 | C7orf25 | C7orf31 | C7orf33 | C7orf50 | C7orf57 | C8A | C8B | C8G | C8orf33 | C8orf34 | C8orf34-AS1 | C8orf44 | C8orf48 | C8orf58 | C8orf74 | C8orf76 | C8orf82 | C8orf88 | C8orf89 | C9 | C9orf131 | C9orf152 | C9orf153 | C9orf163 | C9orf24 | C9orf40 | C9orf43 | C9orf47 | C9orf50 | C9orf57 | C9orf64 | C9orf72 | C9orf78 | C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1